Supramolecular hydrogels enable co-delivery of chemotherapeutics with synergistic efficacy against patient-derived glioblastoma cells and spheroids
RSC Pharmaceutics · 2024 · 1 (4) · 742-754
DOI: 10.1039/d4pm00177j ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Pharmaceutics, 2024. Verfasst von Robert J. Cavanagh und 4 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Engineering and Physical Sciences Research Council, Royal Society.
Abstract (Originalsprache)
Drug combinations have been shown to be highly effective in many cancer therapies but the ratios of the individual drugs must be adjusted carefully and formulated appropriately to ensure synergistic action.
Förderung
- Engineering and Physical Sciences Research Council
- Royal Society
Zitieren
APA
Cavanagh, R. J., Baquain, S., Alexander, C., Scherman, O. A., & Rahman, R. (2024). Supramolecular hydrogels enable co-delivery of chemotherapeutics with synergistic efficacy against patient-derived glioblastoma cells and spheroids. RSC Pharmaceutics, 1(4), 742-754. https://doi.org/10.1039/d4pm00177j
Vancouver
Cavanagh RJ, Baquain S, Alexander C, Scherman OA, Rahman R. Supramolecular hydrogels enable co-delivery of chemotherapeutics with synergistic efficacy against patient-derived glioblastoma cells and spheroids. RSC Pharmaceutics. 2024;1(4):742-754. doi:10.1039/d4pm00177j
BibTeX
@article{Cavanagh2024,
author = {Cavanagh, Robert J. and Baquain, Saif and Alexander, Cameron and Scherman, Oren A. and Rahman, Ruman},
title = {Supramolecular hydrogels enable co-delivery of chemotherapeutics with synergistic efficacy against patient-derived glioblastoma cells and spheroids},
journal = {RSC Pharmaceutics},
year = {2024},
volume = {1},
number = {4},
pages = {742--754},
doi = {10.1039/d4pm00177j}
}
EUVIMED